|
業務類別
|
Medical Devices |
|
業務概覽
|
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world. |
| 公司地址
| 20 Eastbourne Terrace, London, GBR, W2 6LG |
| 電話號碼
| +44 2033250660 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.livanova.com |
| 員工數量
| 3300 |
| Ms. Stephanie Bolton |
President, Global Epilepsy |
-- |
30/04/2025 |
| Mr. Vladimir A. Makatsaria |
Chief Executive Officer and Director |
美元 772.62K |
25/02/2026 |
| Mr. Franco Poletti |
President, Cardiopulmonary |
美元 380.28K |
30/04/2025 |
| Dr. Ahmet Tezel, PhD |
Chief Innovation Officer |
美元 349.04K |
30/04/2025 |
| Mr. Alex Shvartsburg |
Chief Financial Officer and Principal Accounting Officer |
美元 567.89K |
25/02/2026 |
|
|
| Mr. William A. Kozy |
Chairman of the Board |
25/02/2026 |
| Mr. Todd C. Schermerhorn |
Independent Director |
25/02/2026 |
| Ms. Stacy Enxing Seng |
Independent Director |
25/02/2026 |
| Dr. Sharon O'Kane |
Lead Independent Director |
25/02/2026 |
| Mr. Peter M. Wilver |
Independent Director |
25/02/2026 |
| Mr. Francesco Bianchi |
Independent Director |
25/02/2026 |
| Mr. Vladimir A. Makatsaria |
Chief Executive Officer and Director |
25/02/2026 |
| Mr. James Christopher Barry |
Independent Director |
25/02/2026 |
| Mr. Donald J. Zurbay |
Director |
25/02/2026 |
| Ms. Susan M. Podlogar |
Independent Director |
25/02/2026 |
| Ms. Brooke Story |
Independent Director |
25/02/2026 |
|
|
|
|
